Squarepoint Ops LLC raised its position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) by 586.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 75,538 shares of the company's stock after acquiring an additional 64,528 shares during the quarter. Squarepoint Ops LLC's holdings in Aveanna Healthcare were worth $345,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. BNP Paribas Financial Markets acquired a new stake in Aveanna Healthcare in the fourth quarter valued at approximately $35,000. KLP Kapitalforvaltning AS acquired a new stake in shares of Aveanna Healthcare during the fourth quarter worth approximately $35,000. Tower Research Capital LLC TRC grew its position in shares of Aveanna Healthcare by 662.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock worth $36,000 after buying an additional 6,854 shares in the last quarter. Catalyst Funds Management Pty Ltd grew its position in shares of Aveanna Healthcare by 321.4% during the fourth quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock worth $54,000 after buying an additional 9,000 shares in the last quarter. Finally, Sagespring Wealth Partners LLC acquired a new stake in shares of Aveanna Healthcare during the fourth quarter worth approximately $57,000. Institutional investors and hedge funds own 87.96% of the company's stock.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on AVAH shares. UBS Group raised their price target on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the stock a "sell" rating in a research report on Friday, May 9th. Truist Financial decreased their price target on shares of Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating for the company in a research report on Friday, April 11th.
Check Out Our Latest Stock Analysis on Aveanna Healthcare
Aveanna Healthcare Price Performance
Aveanna Healthcare stock opened at $5.51 on Friday. The company has a market cap of $1.07 billion, a PE ratio of -16.21 and a beta of 2.03. The company has a fifty day moving average price of $5.08 and a two-hundred day moving average price of $4.94. Aveanna Healthcare Holdings Inc. has a 12 month low of $2.32 and a 12 month high of $6.19.
Insiders Place Their Bets
In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of Aveanna Healthcare stock in a transaction on Tuesday, April 1st. The shares were sold at an average price of $5.63, for a total value of $31,415.40. Following the completion of the transaction, the insider now owns 1,451,598 shares of the company's stock, valued at $8,172,496.74. The trade was a 0.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, major shareholder Robert M. Williams, Jr. sold 91,061 shares of Aveanna Healthcare stock in a transaction on Thursday, May 8th. The stock was sold at an average price of $5.84, for a total transaction of $531,796.24. Following the completion of the transaction, the insider now directly owns 545,330 shares of the company's stock, valued at approximately $3,184,727.20. This represents a 14.31% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 4,887,612 shares of company stock valued at $26,269,057 over the last 90 days. 7.80% of the stock is owned by company insiders.
Aveanna Healthcare Company Profile
(
Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
